Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Mallinckrodt
Dow
Cantor Fitzgerald
Cerilliant
Julphar
Accenture
Express Scripts
Deloitte

Generated: June 19, 2018

DrugPatentWatch Database Preview

Dicumarol - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for dicumarol and what is the scope of dicumarol patent protection?

Dicumarol
is the generic ingredient in one branded drug marketed by Lilly and Abbvie, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for dicumarol.
Summary for dicumarol
Medical Subject Heading (MeSH) Categories for dicumarol
Synonyms for dicumarol
2-hydroxy-3-[(2-hydroxy-4-oxochromen-3-yl)methyl]chromen-4-one
2H-1-Benzopyran-2-one, 3,3'-methylenebis(4-hydroxy-
2H-1-Benzopyran-2-one, 3,3'-methylenebis(4-hydroxy)-
2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy-
2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy- (9CI)
2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy-(9CI)
2H-1-Benzopyran-2-one,3,3'-methylenebis[4-hydroxy-
2H-1-Benzopyran-2-one,3'-methylenebis[4-hydroxy-
2H-1-Benzopyran-2-one), 3,3'-methylenebis(4-hydroxy-
2H-1-Benzopyran-2-one],3'-methylenebis[4-hydroxy-
3,2-benzopyrone]
3,3 -Methylene-bis[4-hydroxycoumarin]
3,3-Methylene-bis[4-hydroxycoumarin]
3,3'-methanediylbis(4-hydroxy-2H-chromen-2-one)
3,3'-Methyleen-bis(4-hydroxy-cumarine)
3,3'-Methyleen-bis(4-hydroxy-cumarine) [Dutch]
3,3'-Methylen-bis(4-hydroxy-cumarin)
3,3'-Methylen-bis(4-hydroxy-cumarin) [German]
3,3'-Methylene-bis(4-hydroxycoumarin)
3,3'-Methylene-bis(4-hydroxycoumarin), 99%
3,3'-Methylene-bis(4-hydroxycoumarine)
3,3'-Methylene-bis(4-hydroxycoumarine) [French]
3,3'-Methylene-bis[4-hydroxycoumarin]
3,3'-methylenebis(2-hydroxy-4h-chromen-4-one)
3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)
3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)
3,3'-methylenebis(4-hydroxy-2H-chromen-2-one)
3,3'-Methylenebis(4-hydroxycoumarin)
3,3'-Methylenebis[4-hydroxy-1,2-benzopyrone]
3,3'-Methylenebis[4-hydroxy-2H-1-benzopyran-2-one]
3,3'-Methylenebis[4-hydroxycoumarin]
3,3'-Metilen-bis(4-idrossi-cumarina)
3,3'-Metilen-bis(4-idrossi-cumarina) [Italian]
3,3''''''''-methylenebis(4-hydroxy-coumarin
3,3''''''''-methylenebis(4-hydroxycoumarin)
3,3''''''''-methylenebis[4-hydroxycoumarin
3,3&prime
3,3′-Methylenebis(4-hydroxycoumarin)
4-hydroxy-3-((4-hydroxy-2-oxo-2H-chromen-3-yl)methyl)-2H-chromen-2-one
4-hydroxy-3-[(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-2H-chromen-2-one
4-hydroxy-3-[(4-hydroxy-2-oxo-chromen-3-yl)methyl]chromen-2-one
4-hydroxy-3-[(4-hydroxy-2-oxochromen-3-yl)methyl]chromen-2-one
4,4'-Dihydroxy-3,3'-methylene bis coumarin
5-19-06-00682 (Beilstein Handbook Reference)
66-76-2
7QID3E7BG7
AB00051966_05
AC1L19PT
AC1Q699Q
Acadyl
Acavyl
AI3-14546
AK325302
AKOS000520650
Anathrombase
Antitrombosin
Apekumarol
AS-19619
Baracoumin
BBL008904
BDBM35525
Bio-0616
Bis-3,3'-(4-hydroxycoumarinyl)methane
Bis-3,3'-(4-oxycoumarinyl)ethylacetate
bis-hydroxycoumarin
Bis(4-hydroxycoumarin-3-yl)methane
Bishydroxycoumarin
BPBio1_000980
BRD-K82236179-001-05-0
BRN 0335444
BSPBio_000890
BSPBio_002173
C00796
C19H12O6
CAS-66-76-2
CBDivE_003005
CCG-34550
CCRIS 3713
CHEBI:4513
CHEMBL1466
CHEMBL43154
ChemDiv2_003436
Coumarin, 3,3'-methylenebis(4-hydroxy-
Coumarin, 3,3'-methylenebis[4-hydroxy- (8CI)
Coumarin, 3,3'-methylenebis[4-hydroxy-(8CI)
Coumarin,3'-methylenebis[4-hydroxy-
CS-7962
CTK5C5178
Cuma
Cumid
D02TJS
D03798
DB00266
Di-(4-hydroxy-3-coumarinyl)methane
Di-4-hydroxy-3,3'-methylenedicoumarin
Dicoumal
dicoumarin
dicoumarol
Dicoumarol (INN)
Dicoumarolum
Dicoumarolum [INN-Latin]
Dicoumerol
Dicuman
Dicumaol R
Dicumarine
Dicumarinum
Dicumarol (TN)
Dicumarol (USAN)
Dicumarol [INN-Spanish]
Dicumarol [USAN]
Dicumarol, United States Pharmacopeia (USP) Reference Standard
Dicumarolo
Dicumarolo [DCIT]
Dicumarolum
Dicumol
Dikumarol
DivK1c_000896
DOBMPNYZJYQDGZ-UHFFFAOYSA-N
DSSTox_CID_1729
DSSTox_GSID_21729
DSSTox_RID_76296
DTXSID8021729
Dufalone
Dwukumarol
Dwukumarol [Polish]
EINECS 200-632-9
FT-0624734
GTPL6808
H2893
HE020841
HE277837
HE377492
HE377493
HMS1378M04
HMS1570M12
HMS1920E20
HMS2091M10
HMS2097M12
HMS3652P10
HMS502M18
HSDB 3223
HY-N0645
I14-52299
IDI1_000896
KBio1_000896
KBio2_000645
KBio2_003213
KBio2_005781
KBio3_001393
KBioGR_001055
KBioSS_000645
Kumoran
LS-55258
M0216
MCULE-8095183287
melitoxin
MFCD00006857
MolPort-000-422-589
NC 034
NCGC00016296-01
NCGC00016296-02
NCGC00016296-03
NCGC00016296-04
NCGC00016296-05
NCGC00016296-07
NCGC00094650-01
NCGC00094650-02
NINDS_000896
NSC 17860
NSC 221570
NSC 41834
NSC-17860
NSC-756733
NSC17860
NSC221570
NSC41834
NSC756733
Oprea1_150990
Pharmakon1600-01500239
Prestwick_90
Prestwick0_000785
Prestwick1_000785
Prestwick2_000785
Prestwick3_000785
s4299
SBI-0051343.P003
SCHEMBL33891
SCHEMBL33892
SPBio_000248
SPBio_002829
Spectrum_000165
SPECTRUM1500239
Spectrum2_000144
Spectrum3_000387
Spectrum4_000508
Spectrum5_000871
SR-05000001605
SR-05000001605-4
STK801287
symmetric dicoumarol analogue, 1
Temparin
Tox21_110357
Tox21_110357_1
Trombosan
uncoupler of oxidative respiration
UNII-7QID3E7BG7
VZ31493
W-203471
WLN: T66 BOVJ EQ D1- DT66 BOVJ EQ
Y1603
Z57170530
ZINC3869855

US Patents and Regulatory Information for dicumarol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie DICUMAROL dicumarol TABLET;ORAL 005545-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly DICUMAROL dicumarol CAPSULE;ORAL 005509-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie DICUMAROL dicumarol TABLET;ORAL 005545-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie DICUMAROL dicumarol TABLET;ORAL 005545-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Dow
Argus Health
Fuji
Healthtrust
Johnson and Johnson
McKesson
Accenture
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.